[Elsevier] The platform trial in COVID-19 priming and BOOsting (PICOBOO): The reactogenicity of nine licensed COVID-19 vaccines delivered in immunocompetent adults

段静瑜 Post time Half hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-09-18 17:18
Reward10points

journal:Vaccine

Authors:McLeod C; M. Dymock; K.L. Flanagan; M. Plebanski; H. Marshall; M.J. Estcourt; M.C. Tjiam; C.C. Blyth; K. Subbarao; S. Nicholson; S.N. Faust; U. Wadia; R.B. Thornton; Z. Ellis; P. Williams; McKenzie A; J.A. Marsh; C. Foulis; G. Salama; T.L. Snelling; P. Richmond

Published date:2026-10-

DOI:10.1016/j.vaccine.2026.129034

PDF link:https://www.sciencedirect.com/sc ... 264410X26008431/pdf

Article link:https://doi.org/10.1016/j.vaccine.2026.129034

Article Source:Elsevier BV


Remark:
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Return to the list